岳兴长：
密码：牛生个股问，
本次增资方案简介····························7四、向公开引进的战略投资者增资························47四、监事、股东股权冻结或质押况·························23第四章公司基本况·······················24一、本次增资动因······························6三、现任董事、监事、2009-10-28附件下载重庆康卫生物科技有限公司公开引进战略投资者说明书1重庆康卫生物科技有限公司公开引进战略投资者说明书（修订稿）二〇〇九年十月重庆康卫生物科技有限公司公开引进战略投资者说明书2目录第一章释义····················
········4第二章概览····························6一、公司经营况······························24四、本次增资的定价及依据··························51七、主要股东况················15一、公司主要财务指标····························25第五章公司主要资产及研发的疫苗况···············27一、 公开引进战略投资者的确定·························13第三章公司历史沿革、 公开引进战略投资者的条件·························54二、实施本次增资方案的前提条件························53第七章公开引进战略投资者的条件、
重庆康卫概况······························6二、本次增资前持有公司5%以上出资法人股东况介绍··············22三、 公司研发的幽门螺杆疫苗优势分析·····················29五、公开引进战略投资者的评选办法·······················65第八章董事、公司基本况简介····························24二、专家评审小组的人员及构成·························65重庆康卫生物科技有限公司公开引进战略投资者说明书3四、公司主要资产······························27二、精准掌握买卖点大宗交易千股千评行页大盘指数沪深市场涨速排行盘中异动快速选股概念股排行资金流向基金行港股行美股行近访问股票/基金资讯股吧--全部--沪深基金港股上一条下一条金融界页>行中心>岳兴长>个股公告>正文岳兴长深圳:(000819)行报价盘口分析市场异动资金流向加入自选股--(-%)当前价当前价当前价个股概览深度分析大单分析盘口分析资金流向龙虎榜单市场热度财务状况重大事项驱动事件大宗交易融资融券限售解交易数据明细统计大单统计分价统计分时统计资金成本交易提示资讯公告个股资讯个股公告机构评级个股研报基本资料公司概况业绩预告分红送配高管人员股本股东股本结构十大股东流通股东限售股东高管持股基金持股股东户数财务指标核心指标资产负表摘要利润分配表摘要现金流量表摘要财务报表资产负表利润分配表现金流量表所有者权益变动表主营业务业绩报告季度报告中期报告年度报告其他关联方往来公司章程配股公告书招股说明书上市公告书个股公告正文岳兴长： 公司原有股东增资····························39二、 公开引进战略投资者的程序·························64
三、5秒注册忘记密码短信服务每日理财快报手机金融界官方微博设为页加入收夹页财经股票大盘个股新股行港股美股基金理财黄金银行保险募信托期货博客论坛爱股优车优房优品科技我的金融界金融界股票行热门推荐：重庆康卫生物科技有限公司公开引进战略投资者说明书（修订稿）(2009-10-28)_岳兴长(000819)个股公告-金融界用户名：公司知识产权······························27三、公司实施励方案后增加的注册资本·····················44三、公司本次增资实际募集资金金额·······················51六、主要高管人员简历····························&nbs井口公司增资 本次增资的定价及依据··························12五、高级管理人员基本况···················67二、中建机械升降机重庆康卫生物科技有限公司公开引进战略投资者说明书（修订稿）日期：公司人员况······························24三、公司实施本次增资的前提条件························13六、
公司的新证书·····························29四、公司研发的幽门螺杆疫苗况·······················33六、 程序及评选办法·········54一、与公司产品相关的专利况·························37第六章公司本次增资方案·····················39一、
高级管理人员·················67一、
